Inhaled Corticosteroids and COVID-19.
作者信息
Lipworth Brian, Kuo Chris RuiWen, Lipworth Samuel, Chan Rory
机构信息
University of Dundee Dundee, United Kingdom and.
University of Oxford Oxford, United Kingdom.
出版信息
Am J Respir Crit Care Med. 2020 Sep 15;202(6):899-900. doi: 10.1164/rccm.202005-2000LE.
Abstract
摘要
相似文献
1
Inhaled Corticosteroids and COVID-19.吸入性糖皮质激素与新型冠状病毒肺炎
Am J Respir Crit Care Med. 2020 Sep 15;202(6):899-900. doi: 10.1164/rccm.202005-2000LE.
2
COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?新型冠状病毒肺炎、哮喘与吸入性糖皮质激素：吸入性糖皮质激素的又一有益作用？
Am J Respir Crit Care Med. 2020 Jul 1;202(1):8-10. doi: 10.1164/rccm.202005-1651ED.
3
Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?吸入性糖皮质激素与新冠病毒疾病相关死亡率：是混淆因素还是明确因素？
Lancet Respir Med. 2020 Nov;8(11):1065-1066. doi: 10.1016/S2213-2600(20)30447-1. Epub 2020 Sep 24.
4
Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?病毒大流行中的吸入性糖皮质激素：治疗新型冠状病毒肺炎（COVID-19）的方法？
Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.
5
Reply to Lipworth : Inhaled Corticosteroids and COVID-19.对利普沃思的回复：吸入性糖皮质激素与2019冠状病毒病
Am J Respir Crit Care Med. 2020 Sep 15;202(6):900-902. doi: 10.1164/rccm.202006-2129LE.
6
Asthma, biologics, corticosteroids, and coronavirus disease 2019.哮喘、生物制剂、皮质类固醇与2019冠状病毒病
Ann Allergy Asthma Immunol. 2020 Jul;125(1):12-13. doi: 10.1016/j.anai.2020.05.001. Epub 2020 May 6.
7
[COVID-19 and asthma].[新型冠状病毒肺炎与哮喘]
Rev Med Liege. 2020;75(S1):130-132.
8
Authors' response.作者回复。
Ann Allergy Asthma Immunol. 2020 Sep;125(3):362. doi: 10.1016/j.anai.2020.06.018.
9
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019.患有过敏和/或哮喘的儿童及青少年似乎对2019冠状病毒病具有一定的抵抗力。
Ann Allergy Asthma Immunol. 2020 Sep;125(3):361-362. doi: 10.1016/j.anai.2020.06.001.
10
Use of corticosteroids in SARS-CoV-2 infection: foe, or can they become a friend?皮质类固醇在SARS-CoV-2感染中的应用：是敌，还是能成为友？
Pol Arch Intern Med. 2020 Oct 29;130(10):922. doi: 10.20452/pamw.15661.
引用本文的文献
1
Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence study.布地奈德福莫特罗固定剂量复方气雾剂在减轻新冠病毒感染患者咳嗽症状方面的有效性：一项真实世界证据研究。
Lung India. 2023 Mar-Apr;40(2):107-111. doi: 10.4103/lungindia.lungindia_268_22.
2
Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19.肺部药物递送：抗击 COVID-19 的有效且便捷的给药途径。
Drug Deliv Transl Res. 2023 Mar;13(3):705-715. doi: 10.1007/s13346-022-01251-1. Epub 2022 Oct 19.
3
Targeting Selective Autophagy as a Therapeutic Strategy for Viral Infectious Diseases.靶向选择性自噬作为病毒感染性疾病的治疗策略
Front Microbiol. 2022 Apr 28;13:889835. doi: 10.3389/fmicb.2022.889835. eCollection 2022.
4
The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy.严重急性呼吸综合征冠状病毒 2 感染对固有免疫的调节作用及抗击 COVID-19 炎症反应的治疗策略。
J Biomed Sci. 2022 May 3;29(1):27. doi: 10.1186/s12929-022-00811-4.
5
Asthma and coronavirus disease 2019-related outcomes in hospitalized patients: A single-center experience.住院患者的哮喘和 2019 冠状病毒病相关结局：单中心经验。
Ann Allergy Asthma Immunol. 2022 Jul;129(1):79-87.e6. doi: 10.1016/j.anai.2022.03.017. Epub 2022 Mar 24.
6
Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19.质子泵抑制剂的使用与 COVID-19 住院患者的死亡率升高有关。
J Glob Health. 2022 Feb 19;12:05005. doi: 10.7189/jogh.12.05005. eCollection 2022.
7
Drug-based therapeutic strategies for COVID-19-infected patients and their challenges.用于 COVID-19 感染患者的药物治疗策略及其面临的挑战。
Future Microbiol. 2021 Dec;16:1415-1451. doi: 10.2217/fmb-2021-0116. Epub 2021 Nov 23.
本文引用的文献
1
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells.吸入性类固醇 Ciclesonide 通过靶向细胞培养中的病毒复制转录复合物来阻断 SARS-CoV-2 RNA 复制。
J Virol. 2020 Dec 9;95(1). doi: 10.1128/JVI.01648-20.
2
COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?新型冠状病毒肺炎、哮喘与吸入性糖皮质激素：吸入性糖皮质激素的又一有益作用？
Am J Respir Crit Care Med. 2020 Jul 1;202(1):8-10. doi: 10.1164/rccm.202005-1651ED.
3
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19.IL-6 和 CRP 水平升高可预测 COVID-19 患者需要机械通气。
J Allergy Clin Immunol. 2020 Jul;146(1):128-136.e4. doi: 10.1016/j.jaci.2020.05.008. Epub 2020 May 18.
4
Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.2 型炎症调节气道上皮细胞中的 ACE2 和 TMPRSS2。
J Allergy Clin Immunol. 2020 Jul;146(1):80-88.e8. doi: 10.1016/j.jaci.2020.05.004. Epub 2020 May 15.
5
COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.哮喘患者痰液细胞中的 COVID-19 相关基因。与人口统计学特征和皮质类固醇的关系。
Am J Respir Crit Care Med. 2020 Jul 1;202(1):83-90. doi: 10.1164/rccm.202003-0821OC.
6
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2.呼吸道过敏、哮喘与新型冠状病毒受体血管紧张素转换酶2表达的关联。
J Allergy Clin Immunol. 2020 Jul;146(1):203-206.e3. doi: 10.1016/j.jaci.2020.04.009. Epub 2020 Apr 22.
7
Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.格隆溴铵、福莫特罗和布地奈德对人鼻和气管上皮细胞原代培养物中冠状病毒HCoV-229E复制及细胞因子产生的抑制作用。
Respir Investig. 2020 May;58(3):155-168. doi: 10.1016/j.resinv.2019.12.005. Epub 2020 Feb 21.
8
Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol.急性肺损伤导致心血管功能障碍：白细胞介素 6 和布地奈德/福莫特罗的影响。
Am J Respir Cell Mol Biol. 2011 Sep;45(3):510-6. doi: 10.1165/rcmb.2010-0169OC. Epub 2010 Dec 17.
Zotero 插件